SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Journal of Psychopharmacology
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Haddad, P. M.
Right arrow Articles by Wieck, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Haddad, P. M.
Right arrow Articles by Wieck, A.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Antipsychotic induced hyperprolactinaemia: a series of illustrative case reports

Peter M. Haddad

Mental Health Services of Salford, University of Manchester, UK

Jonathan S. E. Hellewell

Trafford General Hospital, University of Manchester, Manchester, UK

Angelika Wieck

Withington Hospital, University of Manchester, Manchester, UK

Hyperprolactinaemia is a common side-effect of many antipsychotic drugs but, in comparison to extrapyramidal side-effects, it has received little attention. Four case reports are presented which illustrate important clinical and pharmacological aspects of the syndrome. Two of the cases were caused by conventional antipsychotic drugs and two by risperidone, an atypical antipsychotic. Symptoms included gynaecomastia, galactorrhoea, amenorrhoea and sexual dysfunction. Three patients were switched to a prolactin sparing antipsychotic leading to normalization of serum prolactin and resolution of the symptoms. Patients prescribed prolactin elevating antipsychotics should, where possible, have this issue explained to them prior to commencing treatment and be screened for symptoms suggestive of hyperprolactinaemia before starting treatment and regularly thereafter.

Key Words: amenorrhoea • antipsychotic • galactorrhoea • hyperprolactinaemia

Journal of Psychopharmacology, Vol. 15, No. 4, 293-295 (2001)
DOI: 10.1177/026988110101500408
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 J PsychopharmacolHome page
D. Kohen and H. J. Wildgust
The evolution of hyperprolactinaemia as an entity in psychiatric patients
J Psychopharmacol, March 1, 2008; 22(2_suppl): 6 - 11.
[Abstract] [PDF]

Home page
 J PsychopharmacolHome page
A. M. Meaney and V. O'Keane
Reduced Bone Mineral Density in Patients with Schizophrenia Receiving Prolactin Raising Anti-Psychotic Medication
J Psychopharmacol, December 1, 2003; 17(4): 455 - 458.
[Abstract] [PDF]

Home page
 Br. J. PsychiatryHome page
A. WIECK and P. M. HADDAD
Antipsychotic-induced hyperprolactinaemia in women: pathophysiology, severity and consequences: Selective literature review
The British Journal of Psychiatry, March 1, 2003; 182(3): 199 - 204.
[Abstract] [Full Text] [PDF]

Home page
 The Annals of PharmacotherapyHome page
A. R. Kunwar and J. L Megna
Resolution of Risperidone-Induced Hyperprolactinemia with Substitution of Quetiapine
Ann. Pharmacother., February 1, 2003; 37(2): 206 - 208.
[Abstract] [Full Text] [PDF]


Advertisement